Core Viewpoint - Mingde Bio (002932.SZ) has signed a partnership agreement to invest in the Wuhan Zesen Juxin No. 2 Venture Capital Partnership, with a total fund size of RMB 95 million [1] Group 1: Investment Details - The fund has been registered and received a business license from the Wuhan Municipal Market Supervision Administration [1] - Mingde Bio is contributing RMB 30 million, holding a 31.5789% stake in the fund [1] - Other investors include Hubei Zhenghan Investment Co., Ltd. and several individual investors, with contributions ranging from RMB 100,000 to RMB 3 million [1] Group 2: Stake Distribution - The ordinary partner, Wuhan Zesen Changsheng Venture Capital Fund Management Co., Ltd., contributes RMB 100,000, holding a 0.1053% stake [1] - Hubei Zhenghan Investment Co., Ltd. also contributes RMB 30 million for a 31.5789% stake [1] - Individual contributions include RMB 1 million from Bao Jie and Fu Shanshan, each holding a 10.5263% stake, and smaller contributions from other individuals [1]
明德生物(002932.SZ):拟与专业机构共同投资合伙企业